Price Comparison

FOXO4-DRI

Senolytic Peptide

15 vendors competing

15 of 15 vendors
Prices for FOXO4-DRI by vendor
VendorPrice10mg costUpdatedActions
Alpha Peptides8/10
8/10
COA ✓Ships: USCredit/debit card
Verification & shipping
8/10
COA ✓Ships: USCredit/debit card
Out of stock
$62.63$69.59−10% · code PEPTIDEPRICES1010mg package$62.63Checked jul 31, 2026Jul 31, 2026Buy FOXO4-DRI from Alpha Peptides
Ascension Peptides8.5/10
8.5/10
COA ✓Ships: USVisa · ACH bank draft
Verification & shipping
8.5/10
COA ✓Ships: USVisa · ACH bank draft
$100.00$199.99−50% · code PEPTIDEPRICES5010mg package$100.00Checked apr 16, 2026Apr 16, 2026Buy FOXO4-DRI from Ascension Peptides
MS Peptides8/10
8/10
COA ✓Ships: US + internationalCredit/debit card · ACH
Verification & shipping
8/10
COA ✓Ships: US + internationalCredit/debit card · ACH
$116.96$129.95−10% · code peptideprices10mg package$116.96Checked aug 19, 2026Aug 19, 2026Buy FOXO4-DRI from MS Peptides
Glacier Aminos8.5/10
8.5/10
COA ✓Ships: USCredit/debit card
Verification & shipping
8.5/10
COA ✓Ships: USCredit/debit card
$121.49$134.99−10% · code peptidep10mg package$121.49Checked jul 31, 2026Jul 31, 2026Buy FOXO4-DRI from Glacier Aminos
Atomik Labz7/10
7/10
COA ✓Ships: US + CanadaPayment not verified
Verification & shipping
7/10
COA ✓Ships: US + CanadaPayment not verified
$149.25$199.00−25% · code peptideprices14mg package$149.25Checked aug 4, 2026Aug 4, 2026Buy FOXO4-DRI from Atomik Labz
Offline Peptides7.5/10
7.5/10
COA ✓Ships: USCredit/debit card
Verification & shipping
7.5/10
COA ✓Ships: USCredit/debit card
$159.0010mg package$159.00Checked jul 28, 2026Jul 28, 2026Buy FOXO4-DRI from Offline Peptides

Research details

FOXO4-DRI — research data

Half-life~2–4 hours. D-amino acid backbone resists proteolysis, extending activity.
Regulatory statusNot FDA-approved
NCAA D1Not listed

Overview

About FOXO4-DRI

Mechanism of action

D-amino acid retro-inverso FOXO4 peptide; disrupts FOXO4-p53 interaction in senescent cells; triggers selective apoptosis of senescent cells (senolytic); clears 'zombie cells' without harming normal cells.

Safety profile

Potential weight loss, lethargy in animal models. Long-term human data very limited. Theoretical risk: removal of beneficial senescent cells in wound healing. · Experimental senolytic that works by disrupting the FOXO4–p53 interaction. p53 is the master tumor-suppressor protein — modulating it carries serious theoretical oncogenic risk, and there is zero human safety data. Animal data only.

Storage

Stability & handling

❄️Lyophilized (powder)−20°Clong-term stable
💉Reconstituted2–8°Cwithin 30 days

Safety & Interactions

Contraindications & Drug Interactions

Research use only — not medical advice. Consult a licensed physician before using any peptide. Sources are cited where available.

! CautionCaution

Experimental senolytic with limited human data. Selectively targets senescent cells in animal studies.

Related pages

More on FOXO4-DRI

Stack & Compare

Frequently Researched Together

Research

Studies & key findings

  • FOXO4-DRI is a D-amino acid retro-inverso peptide that disrupts the interaction between FOXO4 and p53 in senescent cells; in normal senescent cells FOXO4 sequesters p53 in nuclear PML bodies, preventing its pro-apoptotic function — FOXO4-DRI competitively displaces this interaction, causing p53 nuclear exclusion and activation of apoptosis selectively in senescent cells.
  • The landmark 2017 Cell paper demonstrated that FOXO4-DRI restored fitness, fur density, and renal function in both fast-aging XpdTTD/TTD mice and naturally aged mice, and reduced doxorubicin-induced chemotoxicity in a senescence-dependent manner — providing the first in vivo proof that selective senescent cell elimination with a peptide reverses multiple aging-associated phenotypes.

6 peer-reviewed sources cited — clinical, preclinical, and regulatory.

Read full research →
Failed to fetch